Tracking vaccine misconceptions–by mining online data
Fifty years after Boston Children’s Hospital faculty developed a vaccine against measles, the United Kingdom is seeing a surge of cases. Last year, it tracked a record 2,000 measles diagnoses—unusual for a country that used to average only a dozen cases every year. With 1,200 cases reported this year so far, that record could be [Read More]
Technology for all: Teaching robotic surgery in Italy
As the benefits become clear, robotic surgery is getting more popular. Since it’s done laparoscopically, it requires smaller incisions, allowing patients to recover faster and resume normal activity within one to two weeks, as compared with a six- to eight-week recovery time for open surgery. “This is an obvious upside for patients, but for hospitals [Read More]
Who We are
The mission of the Technology and Innovation Development Office (TIDO) is to translate the excellence of the laboratory research and clinical care at Children’s Hospital Boston into lifesaving biomedical products, devices and procedures for the public benefit.
News and Events
Mark Puder, MD, PhD, featured on Rock Center
Mark Puder, MD, PhD, associate in Surgery, developed a treatment with a drug made with fish oil called Omegaven - an omega-3 fatty acid supplement made with fish oil - that he's been using to help reverse fatal liver disease in infants. Despite the drug's effectiveness, it has yet to be approved by the Food and Drug Administration. NBC's Rock Center featured the story on Friday night.
FY 2012 Annual Report released!
The 2012 report highlights TIDO's licensing revenue, specific licenses and collaborations, Technology Development Fund award winners, and selected clinical trial agreements.